Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin. - Suppr | 超能文献

Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.

作者信息

Snydman D, Fink M, Niederman M, Reinhart H

机构信息

New England Medical Center, Boston, Massachusetts, USA.

出版信息

Drugs. 1995;49 Suppl 2:439-41. doi: 10.2165/00003495-199500492-00128.

DOI:10.2165/00003495-199500492-00128

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.

Drugs. 1995;49 Suppl 2:439-41. doi: 10.2165/00003495-199500492-00128.

2

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.住院患者重症肺炎的治疗：一项比较静脉注射环丙沙星与亚胺培南 - 西司他丁的多中心、随机、双盲试验结果。重症肺炎研究组

Antimicrob Agents Chemother. 1994 Mar;38(3):547-57. doi: 10.1128/AAC.38.3.547.

3

Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia.住院重症肺炎患者静脉滴注环丙沙星或亚胺培南治疗后继发感染的临床与经济学评价

J Antimicrob Chemother. 1999 Mar;43 Suppl A:129-34.

4

Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients.环丙沙星与亚胺培南治疗老年住院患者重症肺炎的比较

Drugs. 1995;49 Suppl 2:436-8. doi: 10.2165/00003495-199500492-00127.

5

Results of a randomized trial comparing sequential intravenous/oral treatment with ciprofloxacin plus metronidazole to imipenem/cilastatin for intra-abdominal infections. The Intra-Abdominal Infection Study Group.一项比较环丙沙星加甲硝唑序贯静脉/口服治疗与亚胺培南/西司他丁治疗腹腔内感染的随机试验结果。腹腔内感染研究组。

Ann Surg. 1996 Mar;223(3):303-15. doi: 10.1097/00000658-199603000-00012.

6

Cost effectiveness of ciprofloxacin plus metronidazole versus imipenem-cilastatin in the treatment of intra-abdominal infections.环丙沙星加甲硝唑与亚胺培南-西司他丁治疗腹腔内感染的成本效益

Pharmacoeconomics. 1999 Nov;16(5 Pt 2):551-61. doi: 10.2165/00019053-199916050-00011.

7

Randomized comparative trial of imipenem/cilastatin versus aminoglycoside plus amoxycillin plus clindamycin in the treatment of severe intra- and post-operative infections.亚胺培南/西司他丁与氨基糖苷类加阿莫西林加克林霉素治疗严重手术中和术后感染的随机对照试验

Drugs Exp Clin Res. 1993;19(5):223-7.

8

Comparison of imipenem/cilastatin with the combination of aztreonam and clindamycin in the treatment of intra-abdominal infections.亚胺培南/西司他丁与氨曲南和克林霉素联合用药治疗腹腔内感染的比较。

J Antimicrob Chemother. 1993 Sep;32(3):491-500. doi: 10.1093/jac/32.3.491.

9

Treatment of severe nosocomial pneumonia: a prospective randomised comparison of intravenous ciprofloxacin with imipenem/cilastatin.重症医院获得性肺炎的治疗：静脉用环丙沙星与亚胺培南/西司他丁的前瞻性随机对照研究

Thorax. 2000 Dec;55(12):1033-9. doi: 10.1136/thorax.55.12.1033.

10

Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study.头孢吡肟与亚胺培南-西司他丁治疗重症监护病房患者医院获得性肺炎的多中心、评估者盲法、前瞻性、随机研究。

Antimicrob Agents Chemother. 2003 Nov;47(11):3442-7. doi: 10.1128/AAC.47.11.3442-3447.2003.

引用本文的文献

1

Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults.住院成人社区获得性肺炎非典型病原体的经验性抗生素覆盖。

Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD004418. doi: 10.1002/14651858.CD004418.pub4.

2

Imipenem resistance of Pseudomonas in pneumonia: a systematic literature review.肺炎铜绿假单胞菌的亚胺培南耐药性：系统文献回顾。

BMC Pulm Med. 2010 Aug 26;10:45. doi: 10.1186/1471-2466-10-45.